Aaron Edwards

Aaron Edwards, co-founder of KiraGen Bio, shares his journey from a Harvard Business School project to pioneering a multi-edit CAR T-cell therapy for solid tumors. He discusses tackling immune suppression in glioblastoma, leveraging machine learning, and the challenges of fundraising. Edwards emphasizes the importance of discipline, innovative design strategies, and authentic leadership in the biotech space. His insights offer a fresh perspective on overcoming the complexities of brain cancer treatment while navigating the startup landscape.